STAB VIDA is endowed with ISO9001:2008 certified fully equipped labs, and a specialised personnel with more than 10 years of experience in genetics and genomics. Its main R&D and commercialization interests are focused in point-of-care diagnostics and theragnostics (mainly for Alzheimer, Lyme and Cancer diseases), oligo synthesis, bioinformatics and nucleic acid sequencing, including next-generation sequencing (NGS) for the biotechnology and biomedical research and clinical community.

Main Infrastructures:

- Facilities for extraction, amplification, analysis and storage of nucleic acids, including a robotic pipetting platform, PCR and Real-Time PCR thermocyclers, horizontal and vertical electrophoresis equipment, gel doc systems, centrifuges, freezers, among other laboratory equipment for molecular biology;

- Facilities for sequencing of nucleic acids, including 3x “gold-standard” Sanger-based capillary automatic sequencers (ABI prism 3130 and 3730 systems); 1x Ion torrent (Life Technologies) NGS platform and several computers for genetic analysis, including licenses for CLC Genomics workbench and other bioinformatics tools. It also has access to 1x HiSeq 2500 (illumina) and 1x MiSeq (illumina) NGS platforms for further validation of easierNGS in different NGS platforms.